Antileukemic HLA-restricted T-cell clones generated with naturally processed peptides eluted from acute myeloblastic leukemia blasts

Blood

Volumn 92, Issue 1, 1998, Pages 19-24

  Ostankovitch, Marina ^a   Buzyn, Agnès ^b   Bonhomme, Delphine ^b   Connan, Francine ^b   Bouscary, Didier ^b   Heshmati, Fahrad ^b   Dreyfus, François ^b   Choppin, Jeannine ^b   Guillet, Jean Gérard ^b  

^a INSTITUT COCHIN   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; HLA ANTIGEN; HLA B7 ANTIGEN; PEPTIDE;

ACUTE MYELOBLASTIC LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; ARTICLE; BLAST CELL; CLONE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; LYMPHOCYTE TRANSFUSION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; T LYMPHOCYTE;

EID: 0032127430     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.1.19.413a40_19_24     Document Type: Article

References (18)

1. Van Pel A, Van der Bruggen P, Coolie PG, Brichard VG, Lethe B, Van den Eynde B, Uyttenhove C, Renauld JC, Boon T: Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol Rev 145:229, 1995
2. Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, Eisenbach L: CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369:67, 1994
3. Skipper JCA, Hendrickson RC, Gulden PH, Brichard V, Van Pel A, Chen Y, Shabanowitz J, Wölfel T, Singluff CL, Boon T, Hunt DF, Engelhard VH: An HLA-A2-restricted tyrosinase antigen on melanoma cells results from post-translational modification and suggests a novel pathway for processing of membrane proteins. J Exp Med 183:527, 1996
4. Franksson L, Petersson M, Kiessling R, Kärre K: Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells. Eur J Immunol 23:2606, 1993
5. Pia Protti M, Imro MA, Manfredi A, Consogno G, Heltai S, Arcelloni C, Bellone M, Dellabona P, Casorati G, Rugarli C: Particulate naturally processed peptides prime a cytotoxic response against human melanoma in vitro. Cancer Res 56:1210, 1996
6. Nair SK, Boczkowski D, Snyder D, Gilboa E: Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines. Eur J Immunol 27:589, 1997
7. Bellone M, Iezzi G, Martin-Fontecha A, Rivolta L, Manfredi AA, Pia Protti M, Freschi M, Dellabona P, Casorati G, Rugarli C: Rejection of a nonimmunogenic melanoma by vaccination with natural melanoma peptides on engineered antigen-presenting cells. J Immunol 158:783, 1997
8. Zitvogel L, Mayordamo JI, TjandrawanT, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ: Therapy of murine tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183:87, 1996
9. Giralt SA, Champlin RE: Leukemia relapse after allogeneic bone marrow transplantation: A review. Blood 84:3603, 1994
10. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermueller J, de Whitte T, Holler E, Ansari H: Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86:2041, 1995
11. Storkus WJ, Zeh HJ III, Maeurer MJ, Salter RD, Lotze MT: Identification of human melanoma peptides recognized by class I-restricted tumor infiltrating lymphocytes. J Immunol 151:3719, 1993
12. Gnjatic S, Bressac-de Paillerets B, Guillet JG, Choppin J: Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: Effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules. Eur J Immunol 25:1638, 1995
13. Ostankovitch M, Le Gal FA, Connan F, Chassin D, Choppin J, Guillet JG: Generation of Melan-A/MART-1-specific CD8+ CTL from human naive precursors: Helper effects requirement for efficient in vitro primary CTL induction. Int J Cancer 72:987, 1997
14. Goulmy E: Human minor histocompatibility antigens. Curr Opin Immunol 8:75, 1996
15. van der Harst D, Goulmy E, Falkenburg JHF, Kooij-Winkelaar YMC, van Luxemburg-Hejjs SAP, Goselink HM, Brand A: Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood 83:1060, 1994
16. Falkenburg JHF, Goselink HM, van der Harst D, van Luxemburg-Heijs SAP, Kooij-Winkelaar YMC, Faber LM, de Kroon J, Brand A, Fibbe WE, Willemze R, Goulmy E: Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes. J Exp Med 174:27, 1991
17. Faber LM, Van Luxemburg-Heijs SAP, Willemze R, Falkenburg F: Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. J Exp Med 176:1283, 1992
18. Dolstra H, Fredrix H, Preijers F, Goulmy E, Figdor CG, de Witte TM, van de Wiel-van Kemenade E: Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL. J Immunol 158:560, 1997